It is now well established that ketone bodies (acetoacetate and D-3-hydroxybutyrate) are metabolized by many mammalian tissues and that the rate of utilization is mainly dependent on their availability in the circulation. The aim in this contribution is to summarize briefly the pathways of ketone-body metabolism and to discuss the role of ketone bodies m various tissues. For a detailed review of the physiological roles of ketone bodies the reader is referred to Robinson & Williamson (1980) 
Pathways of ketone-body metabolism
The major metabolic fate of ketone bodies is oxidation, and therefore it is not surprising that the enzymes concerned in their metabolism are mainly located within the mitochondria. The three reactions involved in conversion of ketone bodies into acetyl-CoA are:
Ketone bodies may be thermogenic substrates during the neonatal period, when their concentration in the blood is high , or during cold exposure, when the turnover of ketone bodies is increased (Maekubo et al., 1977) . The liver contains only low activity of the 3-0x0 acid CoA-transferase, and any acetoacetyl-CoA produced from acetoacetate might be reconverted into acetoacetate by the combined action of 3-hydroxy-3-methylglutaryl-CoA synthase (EC 4.1.3.5) and 3-hydroxy-3-methylglutaryl-CoA lyase (EC 4.1.3.4). It has been suggested that such a substrate cycle between acetoacetyl-CoA and acetoacetate may be important in the regulation of ketogenesis (Zammit et al., 1979) . It is of interest that the activity of 3-0x0 acid CoA-transferase increases in hepatomas, and the increase correlates with the growth rate (Fenslau et al., 1975) . There is little or no change in the activities of the mitochondrial enzymes of ketone-body utilization in peripheral tissues of the adult rat in response to short-term fat feeding starvation or insulin deficiency, which indicates that the increased utilization of ketone bodies in these situations is primarily due to their increased availability. It is only in the
Reaction (1) is catalysed by D-3-hydroxybutyrate dehydrogenase (EC 1.1.1.30), which is located in the inner membrane of the mitochondria, and reaction (2) is catalysed by 3-0x0 acid CoA-transferase (EC 2.8.3.5), an enzyme of the mitochondrial matrix. Acetoacetyl-CoA thiolase (EC 2.3.1.9; reaction 3) is distributed between the mitochondrial matrix and the cytosol; it is this latter isoenzyme which plays a role in the extramitochondrial utilization of ketone bodies (see below). The two tissues of the adult rat which have the highest activities of the three enzymes are kidney and heart , closely followed by interscapular brown adipose tissue (Table 1) . The recent demonstration (L. Agius & D. H. Williamson, unpublished work) that brown adipose tissue, but not white, has a high capacity to utilize ketone bodies suggests that they may act as substrates for thermogenesis in this tissue.
neonatal rat that large changes in activity occur, and the net result of these changes is to direct ketone bodies to the developing brain (Williamson, 1973) .
Studies with "C-labelled ketone bodies have indicated that a significant proportion of label is incorporated into the lipid fraction of a number of tissues (Table 2 ). In the rat, the major sites of lipogenesis from ketone bodies are spinal cord and brain in the suckling animal (Cremer & Heath, 1974; Ramsey, 1976; Webber & Edmond, 1977) , the lactating mammary gland (Robinson & Williamson, 1978) Williamson, 1975 ) for provision of acetyl-CoA in the cytosol:
Acetoacetyl-CoA + CoA % 2 acetyl-CoA (5) The carbon of acetoacetate can thus be directly converted into lipid or cholesterol. Acetoacetyl-CoA synthase (reaction 4) is a low-activity enzyme, but it has a higher affinity for acetoacetate than does 3-0x0 acid CoA-transferase (Robinson & Williamson, 1978) . In addition, unlike the transferase, the activity of the enzyme is sensitive to the nutritional state (decreases in starvation).
Enzymes involved in the metabolism of ~-(+)-3-hydroxybutyrate are present in rat tissues (Reed & Ozand, 1980) , and its incorporation into brain lipid has been demonstrated (Webber & Edmond. 1977) . but as yet this isomer has not been detected in the circulation.
Regulation ofsubstrate supply by ketone bodies
Apart from acting as oxidizable substrates and lipid precursors, ketone bodies directly regulate the utilization and production of other substrates. In general, these effects of ketone bodies are brought about by the interactions of ketone-body metabolism on the pathway involving the other substrate.
It has now been demonstrated in a number of rat tissues that ketone bodies decrease glucose utilization and/or the oxidation of pyruvate (Table 2 ). The mechanism for these interactions was established by Randle and co-workers (Randle et al., 1966) . Metabolism of acetoacetate to acetyl-CoA within the mitochondria results in increased formation of citrate. This is transported to the cytosol, where it inhibits phosphofructokinase activity: consequently fructose 6-phosphate and glucose 6-phosphate concentrations rise. The latter is an inhibitor of hexokinase, and therefore glucose removal is inhibited. The inhibition of glucose removal by acetoacetate in mammary gland can be relieved by insulin (Robinson & Williamson, 1977) , although the mechanism of this effect of the hormone is not known. The increased production of pyruvate and lactate in the presence of ketone bodies is due to inactivation of pyruvate dehydrogenase by the increased [acetyl-CoAI/[CoAl ratio in the mitochondria (Kerbey et al.. 1976).
Availability of ketone bodies means that glucose is spared by the mechanisms described above and consequently there is a decreased requirement for glucose synthesis. Ketone bodies can regulate the availability of two important glucose precursors: glycerol and alanine. It is well established that ketone bodies can inhibit adipose-tissue lipolysis either directly or indirectly via stimulation of insulin secretion. This feedback loop provides a mechanism to regulate the rate of ketogenesis (via the availability of non-esterified fatty acids) and the supply of glycerol. It has been demonstrated that infusion of ketone bodies decreases plasma alanine and the release of alanine from muscle (Sherwin et al., 1975) . Palaiologos & Felig (1976) have provided some evidence that ketone bodies decrease alanine production by rat diaphragm via inhibition of glycolysis. A direct inhibition of proteolysis by ketone bodies would make physiological sense, but there is no sound evidence for this at present.
